Modalities for predicting events in patients with ICDs: Expanding the versatility of FDG PET

Takashi Kudo^{1

2}, Arman Erzhanovich Nessipkhan³

Affiliations

¹ Department of Radioisotope Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. tkudo123@nagasaki-u.ac.jp.
² Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. tkudo123@nagasaki-u.ac.jp.
³ Department of Radioisotope Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Editorial

Takashi Kudo et al. J Nucl Cardiol. 2021 Apr.

. 2021 Apr;28(2):478-480.

doi: 10.1007/s12350-021-02569-y. Epub 2021 Mar 9.

Takashi Kudo^{1

2}, Arman Erzhanovich Nessipkhan³

¹ Department of Radioisotope Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. tkudo123@nagasaki-u.ac.jp.
² Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan. tkudo123@nagasaki-u.ac.jp.
³ Department of Radioisotope Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

No abstract available

Comment on

Global and regional cardiac dysfunction quantified by ¹⁸F-FDG PET scans can predict ventricular arrhythmia in patients with implantable cardioverter defibrillator.
Jing R, Sun XX, Hua W, Chen L, Yang SW, Hu YR, Zhang NX, Cai MS, Gu M, Niu HX, Zhang S. Jing R, et al. J Nucl Cardiol. 2021 Apr;28(2):464-477. doi: 10.1007/s12350-020-02515-4. Epub 2021 Mar 9. J Nucl Cardiol. 2021. PMID: 33751472

1. Jing R, Sun XX, Hua W, Liang C, Yang SW, Hu YR et al. Global and regional cardiac dysfunction quantified by ¹⁸F-FDG PET scans can predict ventricular arrhythmia in patients with implantable cardioverter defibrillator. J Nucl Cardiol 2021. Online ahead of print
1. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary. Heart Rhythm 15:e190-e252 - DOI
1. Sanders GD, Hlatky MA, Owens DK (2005) Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 353:1471-1480 - DOI
1. Holbrook R, Higuera L, Wherry K, Phay D, Hsieh Y-C, Lin K-H et al (2020) Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial. PLoS ONE 15:e0241697 - DOI
1. Sabbag A, Suleiman M, Laish-Farkash A, Samania N, Kazatsker M, Goldenberg I et al (2015) Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry. Heart Rhythm 12:2426-2433 - DOI